[1]
A. A. de Oliveira, “THE RECLASSIFICATION OF RX TO OTC DRUGS IN BRAZIL: PERSPECTIVES, CHALLENGES AND OPPORTUNITIES”, REASE, vol. 11, no. 8, pp. 994–998, Aug. 2025, doi: 10.51891/rease.v11i8.20575.